Showing 61-70 of 263 results for "".
Have Trouble Reading in Dim Light?
https://modernod.com/articles/significant-findings/have-trouble-reading-in-dim-light/37773/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatIs AMD on the Rise?
https://modernod.com/articles/significant-findings/is-amd-on-the-rise/37769/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatFailing Sight Tied to Fall Risk
https://modernod.com/articles/significant-findings/failing-sight-tied-to-fall-risk/37766/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatGood Grades = High Refractive Error?
https://modernod.com/articles/significant-findings/good-grades-high-refractive-error/37757/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatRyzumvi Approved to Treat Pharmacologically Induced Mydriasis
https://modernod.com/articles/significant-findings/ryzumvi-approved-to-treat-pharmacologically-induced-mydriasis/37754/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatPrevalence of Keratoconus is 10x Higher Than Previously Thought
https://modernod.com/articles/significant-findings/prevalence-of-keratoconus-is-10x-higher-than-previously-thought/37745/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatThe Era of Retina Disease Treatment Options?
https://modernod.com/articles/significant-findings/the-era-of-retina-disease-treatment-options/37739/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatReading Is … Bad for Your Eyes?
https://modernod.com/articles/significant-findings/reading-is-bad-for-your-eyes/37732/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatPDUFA Date Approaches for Apellis Drug
https://modernod.com/articles/significant-findings/pdufa-date-approaches-for-apellis-drug/37722/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatGlobal Perspectives
https://modernod.com/mod-issues/2022-apr/global-perspectives/38409/